Volume 7 Issue 6
Nov.  2016
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2016  >  7(6): 407-416
Guideline on diagnosis and treatment of recipients with diabetes after organ transplantation in China (2016 edition)[J]. ORGAN TRANSPLANTATION, 2016, 7(6): 407-416. doi: 10.3969/j.issn.1674-7445.2016.06.001
Citation: Guideline on diagnosis and treatment of recipients with diabetes after organ transplantation in China (2016 edition)[J]. ORGAN TRANSPLANTATION, 2016, 7(6): 407-416. doi: 10.3969/j.issn.1674-7445.2016.06.001
shu

Guideline on diagnosis and treatment of recipients with diabetes after organ transplantation in China (2016 edition)

doi: 10.3969/j.issn.1674-7445.2016.06.001
  • Received Date: 2016-07-10
    Available Online: 2021-03-19
  • Publish Date: 2016-11-15
    Abstract
    • FullText(HTML)
  • loading
    • References(50)
  • [1]
    Valderhaug TG, Hjelmesth J, Jenssen T, et al. Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses[J]. Transplantation, 2012, 94(7):714-720. doi: 10.1097/TP.0b013e31825f4434
    [2]
    Siraj ES, Abacan C, Chinnappa P, et al. Risk factors and outcomes associated with posttransplant diabetes mellitus in kidney transplant recipients [J]. Transplant Proc, 2010,42(5):1685-1689. doi: 10.1016/j.transproceed.2009.12.062
    [3]
    Cole EH, Johnston O, Rose CL, et al. Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival [J]. Clin J Am Soc Nephrol, 2008 ,3(3): 814-821. doi: 10.2215/CJN.04681107
    [4]
    Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States [J]. Am J Transplant, 2003,3(2):178-185. doi: 10.1034/j.1600-6143.2003.00010.x
    [5]
    Hjelmesaeth J, Hartmann A, Leivestad T, et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events [J]. Kidney Int, 2006,69(3):588-595. doi: 10.1038/sj.ki.5000116
    [6]
    Chakkera HA, Weil EJ, Castro J, et al. Hyperglycemia during the immediate period after kidney transplantation [J]. Clin J Am Soc Nephrol, 2009,4(4):853-859. doi: 10.2215/CJN.05471008
    [7]
    U.S. Renal Data System. USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States[M]. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013.
    [8]
    Cotovio P, Neves M, Rodrigues L, et al. New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes [J]. Transplant Proc, 2013,45(3):1079-1083. doi: 10.1016/j.transproceed.2013.03.009
    [9]
    Bayer ND, Cochetti PT, Anil Kumar MS, et al. Association of metabolic syndrome with development of new-onset diabetes after transplantation [J]. Transplantation, 2010,90(8): 861-866. doi: 10.1097/TP.0b013e3181f1543c
    [10]
    Annual Data Report of the US Organ Procurement and Transplantation Network (OPTN) and the Scientific Registry of Transplant Recipients (SRTR). Introduction. [J]. Am J Transplant, 2013,13 (Suppl 1):8-10.
    [11]
    Caillard S, Eprinchard L, Perrin P, et al. Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test [J]. Transplantation, 2011,91(7):757-764. http://cn.bing.com/academic/profile?id=2053125629&encoded=0&v=paper_preview&mkt=zh-cn
    [12]
    Hornum M, Jørgensen KA, Hansen JM, et al. New-onset diabetes mellitus after kidney transplantation in Denmark [J]. Clin J Am Soc Nephrol, 2010,5(4):709-716. doi: 10.2215/CJN.05360709
    [13]
    Hecking M, Werzowa J, Haidinger M, et al. Novel views on new-onset diabetes after transplantation: development, prevention and treatment [J]. Nephrol Dial Transplant, 2013,28(3):550-566. doi: 10.1093/ndt/gfs583
    [14]
    Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report-2015; focus theme: early graft failure [J]. J Heart Lung Transplant, 2015,34(10):1244-1254. doi: 10.1016/j.healun.2015.08.003
    [15]
    Abe T, Onoe T, Tahara H, et al. Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation [J]. Transplant Proc, 2014,46(3):865-869. doi: 10.1016/j.transproceed.2013.12.027
    [16]
    Hackman KL, Snell GI, Bach LA. Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study [J]. Diabetes Care, 2014,37(11):2919-2925. doi: 10.2337/dc14-0663
    [17]
    Bergrem HA, Valderhaug TG, Hartmann A, et al. Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy [J]. Clin J Am Soc Nephrol, 2010,5(4):616-622. doi: 10.2215/CJN.07501009
    [18]
    Chakkera HA, Weil EJ, Pham PT, et al. Can new-onset diabetes after kidney transplant be prevented? [J]. Diabetes Care, 2013,36(5):1406-1412. doi: 10.2337/dc12-2067
    [19]
    Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years [J]. Kidney Int, 2001,59(2):732-737. doi: 10.1046/j.1523-1755.2001.059002732.x
    [20]
    Davidson JA, Wilkinson A. New-onset diabetes after transplantation 2003 international consensus guidelines: an endocrinologists view [J]. Diabetes Care, 2004,27(3):805-812. doi: 10.2337/diacare.27.3.805
    [21]
    Sharif A, Hecking M, de Vries AP, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions [J]. Am J Transplant,2014 ,14(9):1992-2000. doi: 10.1111/ajt.12850
    [22]
    Tufton N, Ahmad S, Rolfe C, et al. New-onset diabetes after renal transplantation [J]. Diabet Med, 2014,31(11):1284-1292. doi: 10.1111/dme.2014.31.issue-11
    [23]
    Hagen M, Hjelmesaeth J, Jenssen T, et al. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients [J]. Nephrol Dial Transplant, 2003,18(10):2154-2159. doi: 10.1093/ndt/gfg338
    [24]
    Nam JH, Mun J, Kim S, et al. beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus [J]. Transplantation, 2001,71(10):1417-1423. doi: 10.1097/00007890-200105270-00011
    [25]
    Shimizu M, Iino Y, Terashi A. Improvement of insulin sensitivity after renal transplantation measured by a glucose clamp technique [J]. Nihon Ika Daigaku Zasshi, 1998,65(1):50-54. doi: 10.1272/jnms1923.65.50
    [26]
    Hecking M, Haidinger M, Döller D, et al. Early basal insulin therapy decreases new-onset diabetes after renal transplantation [J]. J Am Soc Nephrol, 2012, 23(4):739-749. doi: 10.1681/ASN.2011080835
    [27]
    Heit JJ, Apelqvist AA, Gu X, et al. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function [J]. Nature, 2006,443(7109):345-349. doi: 10.1038/nature05097
    [28]
    Redmon JB, Olson LK, Armstrong MB, et al. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells [J]. J Clin Invest, 1996,98(12):2786-2793. doi: 10.1172/JCI119105
    [29]
    Herold KC, Nagamatsu S, Buse JB, et al. Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506 [J]. Transplantation, 1993,55(1):186-192. doi: 10.1097/00007890-199301000-00035
    [30]
    Vincenti F, Friman S, Scheuermann E, Rostaing L, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus [J]. Am J Transplant, 2007,7(6):1506-1514. doi: 10.1111/ajt.2007.7.issue-6
    [31]
    Huscher D, Thiele K, Gromnica-Ihle E, et al. Dose-related patterns of glucocorticoid-induced side effects [J]. Ann Rheum Dis, 2009 ,68(7): 1119-1124. doi: 10.1136/ard.2008.092163
    [32]
    Qi D, Rodrigues B. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism [J]. Am J Physiol Endocrinol Metab, 2007 , 292(3): E654-E667. http://cn.bing.com/academic/profile?id=2104954391&encoded=0&v=paper_preview&mkt=zh-cn
    [33]
    Ullrich S, Berchtold S, Ranta F, et al. Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion[J]. Diabetes, 2005,54(4): 1090-1099. doi: 10.2337/diabetes.54.4.1090
    [34]
    Becker B, Kronenberg F, Kielstein JT, et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study[J]. J Am Soc Nephrol, 2005,16(4):1091-1098. doi: 10.1681/ASN.2004090742
    [35]
    Ortega-Camarillo C, Guzmán-Grenfell AM, García- Macedo R, et al. Hyperglycemia induces apoptosis and p53 mobilization to mitochondria in RINm5F cells[J]. Mol Cell Biochem, 2006,281(1/2):163-171. http://cn.bing.com/academic/profile?id=2026367515&encoded=0&v=paper_preview&mkt=zh-cn
    [36]
    Smiley DD, Umpierrez GE. Perioperative glucose control in the diabetic or nondiabetic patient[J]. South Med J, 2006,99(6):580-589; quiz 590-591. doi: 10.1097/01.smj.0000209366.91803.99
    [37]
    Rabkin R, Ryan MP, Duckworth WC. The renal metabolism of insulin[J]. Diabetologia, 1984,27(3):351-357. doi: 10.1007/BF00304849
    [38]
    Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals[J]. Diabetes Care, 2004,27(2):553-591. doi: 10.2337/diacare.27.2.553
    [39]
    Opelz G, Döhler B. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers[J]. Transplantation, 2014 ,97(3):310-315. http://cn.bing.com/academic/profile?id=2033426727&encoded=0&v=paper_preview&mkt=zh-cn
    [40]
    Hackman KL, Bailey MJ, Snell G, et al. Diabetes is a major risk factor for mortality after lung transplantation[J]. Am J Transplant, 2014,14(2):438-445. doi: 10.1111/ajt.12561
    [41]
    Langsford D, Dwyer K. Dysglycemia after renal transplantation: definition, pathogenesis, outcomes and implications for management[J]. World J Diabetes, 2015,6(10):1132-1151. doi: 10.4239/wjd.v6.i10.1132
    [42]
    Yates CJ, Fourlanos S, Colman PG, et al. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin[J]. Transplantation, 2013,96(8):726-731. doi: 10.1097/TP.0b013e3182a012f3
    [43]
    Wilkinson A, Davidson J, Dotta F, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation[J]. Clin Transplant, 2005,19(3):291-298. doi: 10.1111/ctr.2005.19.issue-3
    [44]
    Pham PT, Pham PM, Pham SV, et al. New onset diabetes after transplantation (NODAT): an overview[J]. Diabetes Metab Syndr Obes, 2011,4:175-186. http://cn.bing.com/academic/profile?id=1999249353&encoded=0&v=paper_preview&mkt=zh-cn
    [45]
    Juan Khong M, Ping Chong Ch. Prevention and management of new-onset diabetes mellitus in kidney transplantation[J]. Neth J Med, 2014,72(3):127-134. http://cn.bing.com/academic/profile?id=1444323586&encoded=0&v=paper_preview&mkt=zh-cn
    [46]
    Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients[J]. Am J Transplant, 2009,9(Suppl 3):S1-S155. http://cn.bing.com/academic/profile?id=1990827591&encoded=0&v=paper_preview&mkt=zh-cn
    [47]
    Ghisdal L, Van Laecke S, Abramowicz MJ, et al. New-onset diabetes after renal transplantation: risk assessment and management[J]. Diabetes Care, 2012,35(1):181-188. doi: 10.2337/dc11-1230
    [48]
    Li Y, Xu W, Liao Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function[J]. Diabetes Care, 2004,27(11):2597-2602. doi: 10.2337/diacare.27.11.2597
    [49]
    Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial[J]. Lancet,2008,371(9626):1753-1760. doi: 10.1016/S0140-6736(08)60762-X
    [50]
    Jenssen T, Hartmann A. Prevention and management of transplant-associated diabetes[J]. Expert Opin Pharmacother, 2011,12(17):2641-2655. doi: 10.1517/14656566.2011.628936
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (239) PDF downloads(42) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return